Interferon alfa subtypes and levels of type I interferons in the liver and peripheral mononuclear cells in patients with chronic hepatitis C and controls

Hepatology

Volumn 29, Issue 6, 1999, Pages 1900-1904

  Castelruiz, Y ^a   Larrea, E ^a   Boya, P ^a   Civeira, M P ^a   Prieto, J ^a  

^a UNIVERSITY CLINIC OF NAVARRA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN TISSUE; LIVER LEVEL; MALE; MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0033061552     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.510290625     Document Type: Article

References (33)

1. 1 Sen G, Lengyel P. The interferon system. J Biol Chem 1992 ; 267: 5017–5020. MEDLINE
2. 2 Samuel CE. Antiviral actions of interferon. Interferon‐regulated cellular proteins and their surprisingly selective antiviral activities. Virology 1991 ; 183: 1–11. MEDLINE
3. 3 Tilg H. New Insights into the mechanisms of interferon alfa: an immunoregulatory and anti‐inflammatory cytokine. Gastroenterology 1997 ; 112: 1017–1021. MEDLINE
4. 4 Malefyt RW. The role of type I interferons in the differentiation and function of Th1 and Th2 cells. Semin Oncol 1997 ; 24: S94–S98.
5. 5 Diaz MO, Bohlander S, Allen G. Nomenclature of the human interferon genes. J Interferon Cytokine Res 1996 ; 16: 179–180. MEDLINE
6. 6 Tovey MG, Streuli M, Gresser I, Gugenheim J, Blanchard B, Guymarho J, Vignaux F, et al. Interferon messenger RNA is produced constitutively in the organs of normal individuals. Proc Natl Acad Sci U S A 1987 ; 84: 5038–5042. MEDLINE
7. 7 Huang X, Yuan J, Goddard A, Foulis A, James RFL, Lernmark A, Pujol‐Borreel R, et al. Interferon expression in the pancreases of patients with type I diabetes. Diabetes 1995 ; 44: 658–664. MEDLINE
8. 8 Bisat F, Raj NB, Pitha PM. Differential and cell type specific expression of murine alpha interferon genes is regulated on the transcriptional level. Nucleic Acids Res 1988 ; 16: 6067–6083. MEDLINE
9. 9 Foster GR, Rodrigues O, Ghouze F, Schulte‐Frohlinde E, Testa D, Liao MJ, Stark GR, et al. Different relative activities of human cell‐derived interferon‐α subtypes: IFN‐α8 has very high antiviral potency. J Interferon Cytokine Res 1996 ; 16: 1027–1033. MEDLINE
10. 10 Tanaka N, Taniguchi T. Cytokine gene regulation: regulatory cis‐elements and DNA binding factors involved in the interferon system. Adv Immunol 1992 ; 52: 263–281. MEDLINE
11. 11 MacDonald NJ, Kuhl D, Maguire D, Näf D, Gallant P, Goswamy A, Hug H, et al. Different pathways mediate virus inducibility of the human IFN‐a1 and IFN‐b genes. Cell 1990 ; 60: 767–779. MEDLINE
12. 12 Au WC, Su Y, Raj NBK, Pitha PM. Virus‐mediated induction of interferon‐α gene requires cooperation between multiple binding factors in the interferon‐α promoter region. J Biol Chem 1993 ; 268: 24032–24040. MEDLINE
13. 13 Dent CL, Gewert DR. A regulatory domain within virus‐response element of the interferon‐α1 gene acts as a transcriptional repressor sequence and determinant of cell‐specific gene expression. Eur J Biochem 1996 ; 236: 895–903. MEDLINE
14. 14 Foster GR, Ackrill AM, Goldin RD, Kerr IM, Thomas HC, Stark GR. Expression of the terminal protein region of hepatitis B virus inhibits cellular responses to interferons α and γ double‐stranded RNA. Proc Natl Acad Sci U S A 1991 ; 88: 2888–2892. MEDLINE
15. 15 Bukh J, Miller RH, Purcell RH. Genetic heterogeneity of hepatitis C virus: quasispecies and genotypes. Semin Liver Dis 1995 ; 15: 41–63. MEDLINE
16. 16 Woitas RP, Lechmann M, Jung G, Kaiser R, Sauerbruch T, Spengler U. CD30 induction and cytokine profiles in hepatitis C virus core‐specific peripheral blood T lymphocytes. J Immunol 1997 ; 159: 1012–1018. MEDLINE
17. 17 Gale MJ, Korth MJ, Tang NM, Tan SL, Hopkins DA, Dever TE, Polyak SJ, et al. Evidence that hepatitis C virus resistance to interferon is mediated through repression of the PKR protein kinase by the nonstructural 5A protein. Virology 1997 ; 230: 217–227. MEDLINE
18. 18 Weissmann C, Weber H. The interferon genes. Prog Nucleic Acid Res Mol Biol 1986 ; 33: 251–300. MEDLINE
19. 19 Goeddel DV, Leung DW, Dull TJ, Gross M, Lawn RM, McCandliss R, Seeburg PH, et al. The structure of eight distinct cloned human leukocyte interferon cDNAs. Nature 1981 ; 290: 20–26. MEDLINE
20. 20 Derynck R, Content J, DeClercq E, Volckaert G, Tavernier J, Devos R, Fiers W. Isolation and structure of a human fibroblast interferon gene. Nature 1980 ; 285: 542–547. MEDLINE
21. 21 Ng SY, Gunning P, Eddy R, Ponte P, Leavitt J, Shows T, Kedes L. Evolution of the functional human β‐actin gene and its multi‐pseudogene family: conservation of noncoding regions and chromosomal dispersion of pseudogenes. Mol Cell Biol 1985 ; 5: 2720–2732. MEDLINE
22. 22 Larrea E, García N, Qian C, Civeira MP, Prieto J. Tumor necrosis factor α gene expression and the response to interferon in chronic hepatitis C. Hepatology 1996 ; 23: 210–217. MEDLINE
23. 23 Gavier B, Martínez‐González MA, Riezu‐Boj JI, Lasarte JJ, García N, Civeira MP, Prieto J. Viremia after one month of interferon therapy predicts treatment outcome in patients with chronic hepatitis C. Gastroenterology 1998 ; 113: 1647–1653.
24. 24 Brandt ER, Linnane AW, Devenish RJ. Expression of IFN A genes in subpopulations of peripheral blood cells. Br J Haematol 1994 ; 86: 717–725. MEDLINE
25. 25 Nouri‐Aria KT, Arnold J, Davison F, Portmann BC, Meager A, Morris AG, Alexander GJ, et al. Hepatic interferon‐alpha gene transcripts and products in liver specimens from acute and chronic hepatitis B virus infection. Hepatology 1991 ; 13: 1029–1034. MEDLINE
26. 26 Dienes HP, Hess G, Woorsdorfer M, Rossol S, Gallati H, Ramadori G, Meyer‐zum‐Buschenfelde KH. Ultrastructural localization of interferon‐producing cells in the livers of patients with chronic hepatitis B. Hepatology 1991 ; 13: 321–326. MEDLINE
27. 27 Greenway AL, Hertzog PJ, Devenish RJ, Dudley FJ, McMullen GL, Linnane AW. Immunolocalisation of interferon‐alpha in hepatitis C patients and its correlation with response to interferon‐alpha therapy. J Hepatol 1994 ; 21: 842–852. MEDLINE
28. 28 Ghanekar S, Zheng L, Logar A, Navratil J, Borowski L, Gupta P, Rinaldo C. Cytokine expression by human peripheral blood dendritic cells stimulated in vitro with HIV‐1 and herpes simplex virus. J Immunol 1996 ; 157: 4028–4036. MEDLINE
29. 29 Pestka S, Baron S. Definition and classsification of the interferons. Methods Enzymol 1981 ; 78: 3–14. MEDLINE
30. 30 Reis LFL, Harada H, Wolchok JD, Taniguchi T, Vilcek J. Critical role of a common transcription factor, IRF‐1, in the regulation of IFN‐β and IFN‐inducible genes. EMBO J 1992 ; 11: 185–193. MEDLINE
31. 31 Domanski P, Nadeau OW, Platanias LC, Fish E, Kellum M, Pitha P, Colamonici OR. Differential use of the β L subunit of the type I interferon (IFN) receptor determines signaling specificity for IFNα2 and IFNβ. J Biol Chem 1998 ; 273: 3144–3147. MEDLINE
32. 32 Gil B, Qian C, Riezu‐Boj JI, Civeira MP, Prieto J. Hepatic and extrahepatic HCV RNA strands in chronic hepatitis C: different patterns of response to interferon treatment. Hepatology 1993 ; 18: 1050–1054. MEDLINE
33. 33 Davis GL. Interferon treatment of chronic hepatitis C. Am J Med 1994 ; 96: 41–46.